Specific Regulation of T Helper Cell 1-mediated Murine Colitis by CEACAM1

Journal of Experimental Medicine

Volumn 199, Issue 4, 2004, Pages 471-482

  Iijima, Hideki ^a   Neurath, Markus F ^a,c   Nagaishi, Takashi ^a   Glickman, Jonathan N ^b   Nieuwenhuis, Edward E ^a   Nakajima, Atsushi ^d   Chen, Daohong ^a   Fuss, Ivan J ^e   Utku, Nalan ^f   Lewicki, Daniel N ^g   Becker, Christoph ^c   Gallagher, Thomas M ^g   Holmes, Kathryn V ^h   Blumberg, Richard S ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF COLORADO   (United States)

Author keywords

CEACAM1; Hapten induced colitis; Inflammatory bowel disease; T cell immunity; Th1 cytokine

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CHIMERIC PROTEIN; GAMMA INTERFERON; GLYCOPROTEIN; MONOCLONAL ANTIBODY; OXAZOLONE; STAT PROTEIN; TRINITROBENZENESULFONIC ACID;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELLULAR IMMUNITY; COLITIS; CYTOKINE RELEASE; EFFECTOR CELL; HELPER CELL; IMMUNOPATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; T LYMPHOCYTE ACTIVATION; TH1 CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOEMBRYONIC ANTIGEN; COLITIS; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN FC FRAGMENTS; INFLAMMATION; INTERFERON TYPE II; INTERLEUKIN-1; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; OXAZOLONE; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS;

EID: 10744222880     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20030437     Document Type: Article

References (48)

1. Beauchemin, N., P. Draber, G. Dveksler, P. Gold, S. Gray-Owen, F. Grunert, S. Hammarstrom, K.V. Holmes, A. Karlsson, M. Kuroki, et al. 1999. Redefined nomenclature for members of the carcinoembryonic antigen family. Exp. Cell Res. 252:243-249.
2. Hammarstrom, S. 1999. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin. Cancer Biol. 9:67-81.
3. Kammerer, R., D. Stober, B.B. Singer, B. Obrink, and J. Reimann. 2001. Carcinoembryonic antigen-related cell adhesion molecule 1 on murine dendritic cells is a potent regulator of T cell stimulation. J. Immunol. 166:6537-6544.
4. Moller, M.J., R. Kammerer, F. Grunert, and S. von Kleist. 1996. Biliary glycoprotein (BGP) expression on T cells and on a natural-killer-cell sub-population. Int. J. Cancer. 65:740-745.
5. Chen, T., W. Zimmermann, J. Parker, I. Chen, A. Maeda, and S. Bolland. 2001. Biliary glycoprotein (BGPa, CD66a, CEACAM1) mediates inhibitory signals. J. Leukoc. Biol. 70:335-340.
6. Skubitz, K.M., K.D. Campbell, and A.P. Skubitz. 2000. Synthetic peptides of CD66a stimulate neutrophil adhesion to endothelial cells. J. Immunol. 164:4257-4264.
7. Coutelier, J.P., C. Godfraind, G.S. Dveksler, M. Wysocka, C.B. Cardellichio, H. Noel, and K.V. Holmes. 1994. B lymphocyte and macrophage expression of carcinoembryonic antigen-related adhesion molecules that serve as receptors for murine coronavirus. Eur. J. Immunol. 24:1383-1390.
8. Tan, K., B.D. Zelus, R. Meijers, J.H. Liu, J.M. Bergelson, N. Duke, R. Zhang, A. Joachimiak, K.V. Holmes, and J.H. Wang. 2002. Crystal structure of murine sCEACAM1 a[1,4]: a coronavirus receptor in the CEA family. EMBO J. 21:2076-2086.
9. Thompson, J.A., F. Grunert, and W. Zimmermann. 1991. Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J. Clin. Lab. Anal. 5:344-366.
10. Ravetch, J.V., and L.L. Lanier. 2000. Immune inhibitory receptors. Science. 290:84-89.
11. Watt, S.M., A.M. Teixeira, G.Q. Zhou, R. Doyonnas, Y. Zhang, F. Grunert, R.S. Blumberg, M. Kuroki, K.M. Skubitz, and P.A. Bates. 2001. Homophilic adhesion of human CEACAM1 involves N-terminal domain interactions: structural analysis of the binding site. Blood. 98:1469-1479.
12. Bos, M.P., D. Hogan, and R.J. Belland. 1999. Homologue scanning mutagenesis reveals CD66 receptor residues required for neisserial Opa protein binding. J. Exp. Med. 190:331-340.
13. Virji, M., D. Evans, J. Griffith, D. Hill, L. Serino, A. Hadfield, and S.M. Watt. 2000. Carcinoembryonic antigens are targeted by diverse strains of typable and non-typable Haemophilus influenzae. Mol. Microbiol. 36:784-795.
14. Virji, M., D. Evans, A. Hadfield, F. Grunert, A.M. Teixeira, and S.M. Watt. 1999. Critical determinants of host receptor targeting by Neisseria meningitidis and Neisseria gonorrhoeae: identification of Opa adhesiotopes on the N-domain of CD66 molecules. Mol. Microbiol. 34:538-551.
15. Ergun, S., N. Kilik, G. Ziegeler, A. Hansen, P. Nollau, J. Gotze, J.H. Wurmbach, A. Horst, J. Weil, M. Fernando, et al. 2000. CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. Mol. Cell. 5:311-320.
16. Izzi, L., C. Turbide, C. Houde, T. Kunath, and N. Beauchemin. 1999. cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function. Oncogene. 18:5563-5572.
17. Huang, J., J.D. Hardy, Y. Sun, and J.E. Shively. 1999. Essential role of biliary glycoprotein (CD66a) in morphogenesis of the human mammary epithelial cell line MCF10F. J. Cell Sci. 112:4193-4205.
18. Nakajima, A., H. Iijima, M.F. Neurath, T. Nagaishi, E.E. Nieuwenhuis, R. Raychowdhury, J. Glickman, D.M. Blau, S. Russell, K.V. Holmes, et al. 2002. Activation-induced expression of carcinoembryonic antigen-cell adhesion molecule 1 regulates mouse T lymphocyte function. J. Immunol. 168:1028-1035.
19. Kammerer, R., S. Hahn, B.B. Singer, J.S. Luo, and S. von Kleist. 1998. Biliary glycoprotein (CD66a), a cell adhesion molecule of the immunoglobulin superfamily, on human lymphocytes: structure, expression and involvement in T cell activation. Eur. J. Immunol. 28:3664-3674.
20. Morales, V.M., A. Christ, S.M. Watt, H.S. Kim, K.W. Johnson, N. Utku, A.M. Texieira, A. Mizoguchi, E. Mizoguchi, G.J. Russell, et al. 1999. Regulation Of human intestinal intraepithelial lymphocyte cytolytic function by biliary glycoprotein (CD66a). J. Immunol. 163:1363-1370.
21. Boulton, I.C., and S.D. Gray-Owen. 2002. Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes. Nat. Immunol. 3:229-236.
22. Donda, A., L. Mori, A. Shamshiev, I. Carena, C. Mottet, M.H. Heim, C. Beglinger, F. Grunert, C. Rochlitz, L. Terracciano, et al. 2000. Locally inducible CD66a (CEACAM1) as an amplifier of the human intestinal T cell response. Eur. J. Immunol. 30:2593-2603.
23. Neurath, M.F., I. Fuss, B.L. Kelsall, E. Stuber, and W. Strober. 1995. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182:1281-1290.
24. Elson, C.O., K.W. Beagley, A.T. Shannanov, K. Fujihashi, H. Kiyono, G.S. Tennyson, Y. Cong, C.A. Black, B.W. Ridwan, and J.R. McGhee. 1996. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance. J. Immunol. 157:2174-2185.
25. Boirivant, M., I.J. Fuss, A. Chu, and W. Strober. 1998. Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J. Exp. Med. 188:1929-1939.
26. Nieuwenhuis, E.E., M.F. Neurath, N. Corazza, H. Iijima, J. Trgovcich, S. Wirtz, J. Glickman, D. Bailey, M. Yoshida, P.R. Galle, et al. 2002. Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc. Natl. Acad. Sci. USA. 99:16951-16956.
27. Neurath, M.F., B. Weigmann, S. Finotto, J. Glickman, E. Nieuwenhuis, H. Iijima, A. Mizoguchi, E. Mizoguchi, J. Mudter, P.R. Galle, et al. 2002. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J. Exp. Med. 195:1129-1143.
28. Dveksler, G.S., M.N. Pensiero, C.B. Cardellichio, R.K. Williams, G.S. Jiang, K.V. Holmes, and C.W. Dieffenbach. 1991. Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV. J. Virol. 65:6881-6891.
29. Dveksler, G.S., C.W. Dieffenbach, C.B. Cardellichio, K. McCuaig, M.N. Pensiero, G.S. Jiang, N. Beauchemin, and K.V. Holmes. 1993. Several members of the mouse carcino-embryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59. J. Virol. 67:1-8.
30. Smith, A.L., C.B. Cardellichio, D.F. Winograd, M.S. de Souza, S.W. Barthold, and K.V. Holmes. 1991. Monoclonal antibody to the receptor for murine coronavirus MHV-A59 inhibits viral replication in vivo. J. Infect. Dis. 163:879-882.
31. Wessner, D.R., P.C. Shick, J.H. Lu, C.B. Cardellichio, S.E. Gagneten, N. Beauchemin, K.V. Holmes, and G.S. Dveksler. 1998. Mutational analysis of the virus and monoclonal antibody binding sites in MHVR, the cellular receptor of the murine coronavirus mouse hepatitis virus strain A59. J. Virol. 72:1941-1948.
32. Gallagher, T.M. 1997. A role for naturally occurring variation of the murine coronavirus spike protein in stabilizing association with the cellular receptor. J. Virol. 71:3129-3137.
33. Szabo, S.J., S.T. Kim, G.L. Costa, X. Zhang, C.G. Fathman, and L.H. Glimcher. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 100:655-669.
34. Mach, N., S. Gillessen, S.B. Wilson, C. Sheehan, M. Mihm, and G. Dranoff. 2000. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. Cancer Res. 60:3239-3246.
35. Neurath, M.F., I. Fuss, M. Pasparakis, L. Alexopoulou, S. Haralambous, K.H. Meyer zum Buschenfelde, W. Strober, and G. Kollias. 1997. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur. J. Immunol. 27:1743-1750.
36. Glimcher, L.H., and H. Singh. 1999. Transcription factors in lymphocyte development-T and B cells get together. Cell. 96:13-23.
37. Seder, R.A., R. Gazzinelli, A. Sher, and W.E. Paul. 1993. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA. 90:10188-10192.
38. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189:587-592.
39. Gagneten, S., O. Gout, M. Dubois-Dalcq, P. Rottier, J. Rossen, and K.V. Holmes. 1995. Interaction of mouse hepatitis virus (MHV) spike glycoprotein with receptor glycoprotein MHVR is required for infection with an MHV strain that expresses the hemagglutinin-esterase glycoprotein. J. Virol. 69:889-895.
40. Morris, G.P., P.L. Beck, M.S. Herridge, W.T. Depew, M.R. Szewczuk, and J.L. Wallace. 1989. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 96:795-803.
41. Kanai, T., M. Watanabe, A. Okazawa, T. Sato, M. Yamazaki, S. Okamoto, H. Ishii, T. Totsuka, R. Iiyama, R. Okamoto, et al. 2001. Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease. Gastroenterology. 121:875-888.
42. Stuber, E., W. Strober, and M. Neurath. 1996. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med. 183:693-698.
43. Mullen, A.C., F.A. High, A.S. Hutchins, H.W. Lee, A.V. Villarino, D.M. Livingston, A.L. Kung, N. Cereb, T.P. Yao, S.Y. Yang, et al. 2001. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science. 292:1907-1910.
44. Singer, B.B., I. Scheffrahn, R. Heymann, K. Sigmundsson, R. Kammerer, and B. Obrink. 2002. Carcinoembryonic antigen-related cell adhesion molecule 1 expression and signaling in human, mouse, and rat leukocytes: evidence for replacement of the short cytoplasmic domain isoform by glycosylphosphatidylinositol-linked proteins in human leukocytes. J. Immunol. 168:5139-5146.
45. Latchman, Y., C.R. Wood, T. Chernova, D. Chaudhary, M. Borde, I. Chernova, Y. Iwai, AJ. Long, J.A. Brown, R. Nunes, et al. 2001. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2:261-268.
46. Dohi, T., K. Fujihashi, H. Kiyono, C.O. Elson, and J.R. McGhee. 2000. Mice deficient in Th1- and Th2-type cytokines develop distinct forms of hapten-induced colitis. Gastroenterology. 119:724-733.
47. Spencer, D.M., G.M. Veldman, S. Banerjee, J. Willis, and A.D. Levine. 2002. Distinct inflammatory mechanisms mediate early versus late colitis in mice. Gastroenterology. 122:94-105.
48. Iqbal, N., J.R. Oliver, F.H. Wagner, A.S. Lazenby, C.O. Elson, and C.T. Weaver. 2002. T helper 1 and T helper 2 cells are pathogenic in an antigen-specific model of colitis. J. Exp. Med. 195:71-84.